It is more important than ever to connect and share ideas. The Law Over Lunch series offers FDLI members the exclusive opportunity to engage in facilitated virtual discussions over lunch on topics of interest to the food and drug law community. This event features unique and co-occurring discussion groups, limited to ten attendees per topic to encourage fruitful conversation. This member-only benefit is a chance to closely learn from, educate, and network with other professionals in the field on new and pertinent topics.

Please only sign up for one discussion as they will take place at the same time.

Table Topics and Facilitators


Biden Administration Priorities for FDA and the COVID-19 Pandemic
Vanessa K. Burrows, Counsel, Simpson Thacher & Bartlett LLP

Understanding How Absence of Federal Clarity on CBD Can Impact the Marketplace
Michelle Dimarob, Senior Director, Federal Government Relations, Altria Client Services

Challenges and Priorities for Compliance Programs in 2021
Hannah Bornstein, Partner, Nixon Peabody, Government Investigations & White Collar Defense

Proposed Regulatory Framework for Modifications to Artificial Intelligence/ Machine Learning- Based Software as a Medical Device
Priya Mannan, Associate General Counsel, Novartis Pharmaceuticals

Regulatory and Legal Implications of Innovative Clinical Trial Designs and Tools in Biologics and Drugs
Jacqueline R. Berman, Partner, Morgan, Lewis & Bockius LLP

February 18, 2021
12:00-1:00 PM

Registration is open to FDLI members only and is first come, first served.

This is a complimentary virtual event.


For questions, please contact Tess Garraty.